本頁面由Tiger Trade Technology Pte. Ltd.提供服務

MoonLake Immunotherapeutics

12.51
-0.6700-5.08%
盤後12.620.1100+0.88%19:51 EDT
成交量:238.72萬
成交額:3,052.39萬
市值:10.65億
市盈率:-3.28
高:13.55
開:13.33
低:12.47
收:13.18
52周最高:62.75
52周最低:5.95
股本:8,510.67萬
流通股本:5,546.84萬
量比:1.80
換手率:4.30%
股息:- -
股息率:- -
每股收益(TTM):-3.8139
每股收益(LYR):-3.5300
淨資產收益率:-67.47%
總資產收益率:-32.44%
市淨率:2.49
市盈率(LYR):-3.54

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/10

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/10

重要事件披露

Form 8-K - Current report
2026/07/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/15

重要事件披露

Form 8-K - Current report
2026/06/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/25

重要事件披露

Form 8-K - Current report
2026/06/22

重要事件披露

Form 8-K - Current report
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/09

重要事件披露

Form 8-K - Current report
2026/06/01

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/11

重要事件披露

Form 8-K - Current report
2026/04/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities